Pharmacosmos A/S

🇩🇰Denmark

Country: 🇩🇰Denmark

Ownership: Subsidiary

Employees: -

Market Cap: -

Website: http://www.pharmacosmos.com

Clinical Trials

Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for the Treatment of Iron Deficiency Anemia (IDA)

Phase 3

Completed

Conditions: Iron Deficiency Anaemia
Iron Deficiency Anemia

Interventions: Drug: Iron isomaltoside/ferric derisomaltose
Drug: Iron sucrose

First Posted Date: 2016-10-21

Last Posted Date: 2020-10-06

Lead Sponsor: Pharmacosmos A/S

Target Recruit Count: 1512

Registration Number: NCT02940886

Locations: 🇺🇸
Pharmacosmos Investigational Site, Tacoma, Washington, United States
🇺🇸
Pharmacosmos Investigational Site 1, East Setauket, New York, United States
🇺🇸
Pharmacosmos Investigational Site 2, East Setauket, New York, United States

IV Iron Treatment of Restless Legs Syndrome

Phase 2

Withdrawn

Conditions: Restless Legs Syndrome

Interventions: Drug: Sodium Chloride 0.9%
Drug: Iron isomaltoside 1000

First Posted Date: 2015-06-30

Last Posted Date: 2015-06-30

Lead Sponsor: Pharmacosmos A/S

Registration Number: NCT02484768

A Non-interventional Study of Diafer in Subjects With CKD on Haemodialysis for Treatment of Iron Deficiency

Completed

Conditions: Anaemia in Chronic Kidney Disease

First Posted Date: 2014-11-25

Last Posted Date: 2017-06-14

Lead Sponsor: Pharmacosmos A/S

Target Recruit Count: 209

Registration Number: NCT02301026

Locations: 🇬🇧
Morriston Hospital, Renal Department, Swansea, Wales, United Kingdom
🇸🇪
Heleneholmsdialysen, Malmö, Sweden

A Randomized, Double-blind, Comparative Study of Intravenous Iron Isomaltoside 1000 (Monofer®) Against Placebo

Phase 3

Withdrawn

Conditions: Iron Deficiency Anemia

Interventions: Drug: Natrium Chloride 0,9%
Drug: Iron isomaltoside 1000

First Posted Date: 2014-06-24

Last Posted Date: 2016-09-28

Lead Sponsor: Pharmacosmos A/S

Registration Number: NCT02172001

IDA-01 A Randomised, Open-Label, Comparative Study of Intravenous Iron Isomaltoside 1000 (Monofer®) and Iron Sucrose

Phase 3

Completed

Conditions: Iron Deficiency Anaemia

Interventions: Drug: iron isomaltoside 1000 (Monofer®)
Drug: iron sucrose (Venofer®)

First Posted Date: 2014-05-02

Last Posted Date: 2018-09-27

Lead Sponsor: Pharmacosmos A/S

Target Recruit Count: 511

Registration Number: NCT02130063

Time to Relapse of Iron Deficiency Anemia After Standard Treatment With a New Intravenous Iron (Monofer®)

Completed

Conditions: Iron Deficiency Anemia

Interventions: Drug: 10% Iron Isomaltoside 1000

First Posted Date: 2013-07-16

Last Posted Date: 2016-03-02

Lead Sponsor: Pharmacosmos A/S

Target Recruit Count: 391

Registration Number: NCT01900197

Treatment of Women After Severe Postpartum Haemorrhage

Phase 3

Completed

Conditions: Severe Postpartum Haemorrhage

Interventions: Drug: Red blood cell transfusion
Drug: Iron isomaltoside 1000

First Posted Date: 2013-07-10

Last Posted Date: 2015-08-19

Lead Sponsor: Pharmacosmos A/S

Target Recruit Count: 13

Registration Number: NCT01895205

Treatment of Women After Postpartum Haemorrhage

Phase 3

Completed

Conditions: Postpartum Haemorrhage

Interventions: Other: Standard medical Care
Drug: Iron isomaltoside 1000

First Posted Date: 2013-07-10

Last Posted Date: 2015-04-29

Lead Sponsor: Pharmacosmos A/S

Target Recruit Count: 200

Registration Number: NCT01895218

A Study of Intravenous Iron Isomaltoside 1000 (Monofer®) Administered by Infusions to Iron-deficient Blood Donors

Phase 3

Completed

Conditions: Iron-deficiency

Interventions: Drug: Placebo
Drug: Iron isomaltoside 1000 (Monofer®)

First Posted Date: 2013-07-10

Last Posted Date: 2018-03-15

Lead Sponsor: Pharmacosmos A/S

Target Recruit Count: 107

Registration Number: NCT01895231

Iron Isomaltoside 1000 (Monofer®) Administered by a High Dosing Regimen in Subjects With Inflammatory Bowel Disease

Phase 3

Completed

Conditions: Inflammatory Bowel Disease

Interventions: Drug: Iron Isomaltoside 1000

First Posted Date: 2012-05-16

Last Posted Date: 2015-04-29

Lead Sponsor: Pharmacosmos A/S

Target Recruit Count: 21

Registration Number: NCT01599702

Locations: 🇩🇰
Pharmacosmos A/S, Hoelbaek, Denmark

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy